Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1959 1
1961 7
1962 2
1963 3
1964 6
1965 4
1966 4
1968 1
1969 10
1970 7
1971 2
1972 3
1973 5
1974 14
1975 10
1976 4
1977 5
1978 13
1979 14
1980 16
1981 18
1982 22
1983 26
1984 21
1985 25
1986 21
1987 31
1988 25
1989 43
1990 48
1991 54
1992 43
1993 63
1994 79
1995 85
1996 87
1997 81
1998 78
1999 75
2000 85
2001 65
2002 66
2003 74
2004 77
2005 77
2006 66
2007 82
2008 77
2009 64
2010 82
2011 63
2012 74
2013 72
2014 75
2015 95
2016 132
2017 160
2018 127
2019 100
2020 98
2021 105
2022 99
2023 99
2024 121
2025 106
2026 53

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,169 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: nishikawa t. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brűdgam D, Li Q, Song Y, Hu J, Yang S, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu VC, Vaidya A, Araujo-Castro M, Kocjan T, O'Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Sholinyan J, Fardella CE, Uslar T, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Wu X, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF Jr, Williams TA, Fuller PJ. Yang J, et al. Among authors: nishikawa t. Lancet Diabetes Endocrinol. 2025 Feb;13(2):119-133. doi: 10.1016/S2213-8587(24)00308-5. Epub 2025 Jan 14. Lancet Diabetes Endocrinol. 2025. PMID: 39824204
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.
Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J. Mulatero P, et al. Among authors: nishikawa t. J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510. J Hypertens. 2020. PMID: 32890264 Free article.
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial.
Nishikawa T, Hasegawa K, Matsumoto K, Mori M, Hirashima Y, Takehara K, Ariyoshi K, Kato T, Yagishita S, Hamada A, Kawasaki M, Kawashima S, Tomatsuri S, Nagasaka Y, Yoshida H, Machida R, Hirakawa A, Nakamura K, Yonemori K. Nishikawa T, et al. J Clin Oncol. 2023 May 20;41(15):2789-2799. doi: 10.1200/JCO.22.02558. Epub 2023 Mar 28. J Clin Oncol. 2023. PMID: 36977309 Free PMC article.
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: nishikawa t. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer.
Loeffler CML, Bando H, Sainath S, Muti HS, Jiang X, van Treeck M, Reitsam NG, Carrero ZI, Meneghetti AR, Nishikawa T, Misumi T, Mishima S, Kotani D, Taniguchi H, Takemasa I, Kato T, Oki E, Tanwei Y, Durgesh W, Foersch S, Brenner H, Hoffmeister M, Nakamura Y, Yoshino T, Kather JN. Loeffler CML, et al. Among authors: nishikawa t. Nat Commun. 2025 Aug 14;16(1):7561. doi: 10.1038/s41467-025-62910-8. Nat Commun. 2025. PMID: 40813777 Free PMC article.
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.
Nishio S, Nishikawa T, Mori M, Kamiura S, Sumi T, Yunokawa M, Imai Y, Kondo E, Takehara K, Takano H, Kudaka W, Kado N, Yamagami W, Kato H, Nishino K, Usami T, Hamanishi J, Nii M, Takaya I, Okamoto A. Nishio S, et al. Among authors: nishikawa t. J Gynecol Oncol. 2025 Jul;36(4):e118. doi: 10.3802/jgo.2025.36.e118. J Gynecol Oncol. 2025. PMID: 40590327 Free PMC article. Clinical Trial.
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.
Sanomachi T, Shimoi T, Kojima Y, Takahashi H, Arakaki M, Kawachi A, Okuma HS, Hoshino M, Ito M, Saito A, Kita S, Maejima A, Nishikawa T, Sudo K, Mori T, Fujiwara Y, Yonemori K. Sanomachi T, et al. Among authors: nishikawa t. Head Neck. 2025 Oct;47(10):2735-2741. doi: 10.1002/hed.28190. Epub 2025 May 19. Head Neck. 2025. PMID: 40390268 Free PMC article.
3,169 results